Blood plasma is the liquid component of blood constituting the extracellular matrix. Blood plasma plays a crucial role in maintaining the electrolyte and osmotic balance whilst preventing infection and blood disorders in the body. It primarily consists of water along with other components such as immunoglobulin, dissolved proteins, glucose, clotting factors, electrolytes and hormones. Plasma derivatives are the concentrates of specific proteins which require pooling of plasma from large number of donors. For instance, it requires more than hundred plasma donations to produce sufficient immunoglobulin for treating an immune deficient patient for one year. This has resulted in lucrative opportunities for technological innovations to improve the productivity of plasma derived products. Rising demand for plasma derived products owing to a huge patient pool and unavailability of alternative treatments, would drive the market to the next level. For instance, in case of haemophilia, currently there is no definite cure, and the patient may require a lifelong infusion of plasma derived products. The major factors contributing in the market growth are, rising disease awareness and education, organized network of donor centres and increasing commitment to research. However, high cost of treatment and safety concerns associated with blood transfusion, are likely to restrict the growth of market.
The global blood plasma derivatives market is segmented on the basis of type, application and geography. On the basis of type, the market is segmented into, Fresh Frozen Plasma (FFP), Intravenous immunoglobulin (IVIG), Albumin, Factor VIII, Factor IX and Other components. The market, on the basis of application is segmented into Hemophilia A, Hemophilia B, Von Willebrand Disease and Other Factor Deficiencies. Geographically, the market is segmented across four regions namely North America, Europe, Asia Pacific, and LAMEA.
Few strategies adopted by industry players are acquisition and geographical expansion. For instance, Grigols, market leader in plasma products, has acquired numerous companies in the past few years such as Progenika biopharma, Araclon Biotech, and Talecris Biotherapeutics. In Jan 2014, Grigols acquired the blood transfusion diagnostics unit of Novartis AG to reinforce its business. The company has also expanded its geographic presence in regions such as India, Japan, Switzerland and China. The companies profiled in the report include, Grifols, S.A., Baxter International Inc., CSL Limited, Octapharma AG, Kedrion S.p.A, LFB S.A., Bain Capital, LLC and Biotest AG.
KEY MARKET BENEFITS
The global blood plasma derivatives market is segmented below:
Global Blood Plasma Derivatives Market - By Type
Global Blood Plasma Derivatives Market - By Application
Global Blood Plasma Derivatives Market - By Geography
SIMILAR MARKET STUDIES
Notes: Production, means the output of Immunohistochemistry Revenue, means the sales value of Immunohistochemistry This report studies Immunohistochemistry in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering A.G. Scientific, Inc. ...
August 2016 | $2900 | View Details >>
About This ReportThis new 280-page report from VPGMarketResearch.com presents detailed analysis of the Spanish STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition ...
February 2017 | $0 | View Details >>
This new 269-page report from Venture Planning Group provides a comprehensive analysis in the French endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers.
January 2014 | $1500 | View Details >>
2016 Slovenia Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities for Suppliers
This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years. Highlights - Five-year test volume and sales forecasts - Feature comparison of major analyzers - Profiles of market players and start-up firms developing innovative ...
February 2016 | $0 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research